Opaleye Management Inc. Closed Holding Positions

Opaleye Management Inc.

  • $390 Million
  • Q2 2024
Stock Closed Quarter Shares Sold Price Range Trade History
BCYC
Bicycle Therapeutics PLC

Healthcare
Q2 2022 Filed on Aug 15, 2022
175,000
$12.95 - $46.99 $2.27M - $8.22M
SMLR
Semler Scientific, Inc.

Healthcare
Q2 2022 Filed on Aug 15, 2022
70,000
$27.86 - $50.32 $1.95M - $3.52M
SYBX
Synlogic, Inc.

Healthcare
Q2 2022 Filed on Aug 15, 2022
984,200
$0.89 - $2.47 $876K - $2.43M
AVEO
Aveo Pharmaceuticals, Inc.

Healthcare
Q2 2022 Filed on Aug 15, 2022
240,000
$3.51 - $6.67 $842K - $1.6M
NCNA
Nu Cana PLC

Healthcare
Q2 2022 Filed on Aug 15, 2022
878,700
$0.59 - $1.06 $518K - $931K
BBIO
Bridge Bio Pharma, Inc.

Healthcare
Q1 2022 Filed on May 16, 2022
328,100
$7.34 - $17.16 $2.41M - $5.63M
MEIP
Mei Pharma, Inc.

Healthcare
Q1 2022 Filed on May 16, 2022
1,315,000
$0.54 - $2.74 $710K - $3.6M
SRRA
Sierra Oncology, Inc.

Healthcare
Q1 2022 Filed on May 16, 2022
165,778
$15.51 - $36.85 $2.57M - $6.11M
FOLD
Amicus Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
320,800
$9.82 - $12.44 $3.15M - $3.99M
LPTX
Leap Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
476,000
$2.08 - $3.65 $990K - $1.74M
AKBA
Akebia Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
311,300
$2.26 - $3.34 $704K - $1.04M
VIRX
Viracta Therapeutics, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
258,556
$3.37 - $7.91 $871K - $2.05M
DCPH
Deciphera Pharmaceuticals, Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
205,381
$7.7 - $37.13 $1.58M - $7.63M
SIOX
Sio Gene Therapies Inc.

Healthcare
Q4 2021 Filed on Feb 14, 2022
955,000
$1.29 - $2.36 $1.23M - $2.25M
Adamas Pharmaceuticals Inc
Q4 2021 Filed on Feb 14, 2022
1,460,000
N/A
Aptose Biosciences Inc
Q4 2021 Filed on Feb 14, 2022
549,000
N/A
DTIL
Precision Biosciences Inc

Healthcare
Q4 2021 Filed on Feb 14, 2022
163,900
$7.4 - $11.66 $1.21M - $1.91M
SELB
Selecta Biosciences Inc

Healthcare
Q4 2021 Filed on Feb 14, 2022
106,000
$2.89 - $4.43 $306K - $470K
MCRB
Seres Therapeutics, Inc.

Healthcare
Q3 2021 Filed on Nov 16, 2021
250,000
$5.46 - $22.6 $1.37M - $5.65M
CDTX
Cidara Therapeutics, Inc.

Healthcare
Q3 2021 Filed on Nov 16, 2021
73,351
$1.48 - $2.35 $109K - $172K
CFRX
Contrafect Corp

Healthcare
Q3 2021 Filed on Nov 16, 2021
57,900
$3.19 - $4.43 $185K - $256K
Cerecor Inc
Q3 2021 Filed on Nov 16, 2021
1,567,494
N/A
PHVS
Pharvaris N.V.

Healthcare
Q3 2021 Filed on Nov 16, 2021
79,837
$13.14 - $20.97 $1.05M - $1.67M
Cm Life Sciences Inc
Q3 2021 Filed on Nov 16, 2021
373,828
N/A
EPIX
Essa Pharma Inc.

Healthcare
Q3 2021 Filed on Nov 16, 2021
284,050
$7.76 - $29.37 $2.2M - $8.34M
CRDF
Cardiff Oncology, Inc.

Healthcare
Q3 2021 Filed on Nov 16, 2021
463,000
$5.01 - $7.58 $2.32M - $3.51M
FGEN
Fibrogen Inc

Healthcare
Q2 2021 Filed on Aug 16, 2021
147,000
$18.57 - $35.68 $2.73M - $5.24M
AUTL
Autolus Therapeutics PLC

Healthcare
Q2 2021 Filed on Aug 16, 2021
2,112,918
$4.78 - $7.96 $10.1M - $16.8M
BHVN
Biohaven Pharmaceutical Holding CO Ltd.

Healthcare
Q2 2021 Filed on Aug 16, 2021
25,000
$65.78 - $105.02 $1.64M - $2.63M
MGTA
Magenta Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
88,400
$9.76 - $14.15 $863K - $1.25M
SMTI
Sanara Med Tech Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
225,000
$22.86 - $36.95 $5.14M - $8.31M
GMTX
Gemini Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
810,500
$6.32 - $14.02 $5.12M - $11.4M
MYOV
Myovant Sciences Ltd.

Healthcare
Q2 2021 Filed on Aug 16, 2021
249,800
$17.07 - $24.56 $4.26M - $6.14M
Aerpio Pharmaceuticals Inc
Q2 2021 Filed on Aug 16, 2021
1,000,000
N/A
ALPN
Alpine Immune Sciences, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
156,500
$8.81 - $15.03 $1.38M - $2.35M
AYLA
Ayala Pharmaceuticals, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
108,551
$9.2 - $11.3 $999K - $1.23M
IMVT
Immunovant, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
467,000
$9.4 - $16.85 $4.39M - $7.87M
CBIO
Catalyst Biosciences, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
1,250,000
$4.1 - $5.33 $5.13M - $6.66M
CKPT
Checkpoint Therapeutics, Inc.

Healthcare
Q2 2021 Filed on Aug 16, 2021
2,925,963
$2.36 - $3.2 $6.91M - $9.36M
Highcape Capital Acquisition Corp
Q2 2021 Filed on Aug 16, 2021
241,300
N/A
Five Prime Therapeutics Inc
Q1 2021 Filed on May 18, 2021
381,900
N/A
AMRN
Amarin Corp Plcuk

Healthcare
Q1 2021 Filed on May 18, 2021
225,000
$5.03 - $8.8 $1.13M - $1.98M
Fs Dev Corp
Q1 2021 Filed on May 18, 2021
704,400
N/A
Eidos Therapeutics Inc
Q1 2021 Filed on May 18, 2021
315,550
N/A
INFI
Infinity Pharmaceuticals, Inc.

Healthcare
Q1 2021 Filed on May 18, 2021
3,171,800
$1.98 - $5.36 $6.28M - $17M
AKUS
Akouos, Inc.

Healthcare
Q1 2021 Filed on May 18, 2021
45,459
$13.87 - $21.04 $631K - $956K
CCXI
Chemo Centryx, Inc.
Q1 2021 Filed on May 18, 2021
350,000
$49.53 - $68.4 $17.3M - $23.9M
Catabasis Pharmaceuticals Inc
Q1 2021 Filed on May 18, 2021
187,750
N/A
CNCE
Concert Pharmaceuticals, Inc.

Healthcare
Q1 2021 Filed on May 18, 2021
254,000
$4.86 - $13.07 $1.23M - $3.32M
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email